Massachusetts H1222 prohibits insurers from requiring annual re-authorizations for certain prescription drugs.
Massachusetts H1222 prohibits insurers from requesting or requiring annual re-authorizations for any prescription drug prescribed to treat chronic diseases. This law applies to licensed health insurers subject to specific chapters of the General Laws. The bill aims to alleviate the burden on patients and healthcare providers by eliminating the need for repeated authorizations for ongoing treatment of chronic conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.